Who Andrew Wakefield was—and how he was involved
Wakefield was not a commentator who became attached to the story later. He led the Royal Free research and was the first-named author of the 1998 Lancet case series, which described 12 children but could not establish that MMR caused autism.
He also took the claim directly into public debate. At the paper's press launch, Wakefield recommended that parents use separate vaccines rather than MMR. A Parliamentary Office of Science and Technology review records that intervention, the ensuing media coverage and the fall in vaccination rates that followed. That combination of research leadership and public advocacy is why he is central to this history.
This page documents that role without inventing a death total, blaming every later change in coverage on one person or turning a complex public-health history into an unsupported single-cause story.
Documented timeline
Evidence ledger
| Question | What the record supports | Source |
|---|---|---|
| Did the 1998 paper prove MMR caused autism? | No. It was a 12-child case series, could not establish causation and was later retracted. | Lancet record |
| Were there findings of professional misconduct? | Yes. The GMC panel's findings were reported in January 2010, and Wakefield was later removed from the register. | BMJ report |
| Were undisclosed interests and record discrepancies reported? | Yes. The BMJ investigation documents litigation-related funding and discrepancies between the publication and clinical records. Readers should consult the investigation for the exact amounts and chronology. | BMJ investigation |
| Can one defensible number be assigned to deaths “caused by Wakefield”? | Not from the evidence reviewed for this site. Immunisation decisions, access, service provision and misinformation have multiple causes. Immunity Map therefore publishes no invented global or UK death-attribution total. | UKHSA context |
Financial interests, stated carefully
The BMJ investigation reported that Wakefield undertook legal-aid-funded work connected to planned litigation and that relevant interests were not disclosed in the Lancet paper. It also examined plans and intellectual-property interests relating to alternative products.
Rather than asserting that a later aggregate payment total was all received before publication, this site links to the underlying investigation. That lets readers distinguish when payments began, what the total represented and which facts were established by which source.
The present UK context
The Wakefield episode contributed to a major loss of confidence in MMR. It is not accurate, however, to say that national coverage fell to 73% or that it never recovered. Official reporting places England's MMR1 low point at 79.9% in 2003–04, followed by substantial recovery. Read the National Audit Office figures.
The UK later lost measles elimination status based on 2024 transmission data. UKHSA discusses current coverage, outbreaks and elimination status without attributing the entire modern situation to one historical actor. Access barriers, inequalities, service disruption and contemporary misinformation also matter.
Read the current UKHSA elimination assessment
The established facts are serious enough. Unsupported death totals, fabricated-looking quotations or single-cause stories make accurate criticism easier to dismiss.
The defensible conclusion: the original article did not establish an MMR-autism link; it was retracted; Wakefield was struck off; and the BMJ investigation described the article as fraudulent. Large subsequent studies do not find that MMR increases autism risk.